Disrupting a Mature Market

Proleukin is the only immunotherapy that offers the possibility of a complete response in treating metastatic melanoma and renal cell carcinoma. Oncologists are keenly aware that time is not on their side. Proleukin has been shown to produce a durable complete response lasting beyond 10 years.

The reboot of the Proleukin brand amplifies this message using the Proleukin Survivor Network as basis for the website. A direct and powerful message is used: "I survived metastatic melanoma. You can too. Ask your oncologist about Proleukin. There is no time to waste."

Selfies submitted by actual survivors from the Proleukin Survivor Network are used to add authenticity to the message.